Truace
Subscribe

EDIT-B consortium: an external pan-European validation of an innovative machine learning-based test for bipolar disorder diagnosis

Background Differentiating bipolar disorder (BD) from major depressive disorder (MDD) during major depressive episodes remains a significant challenge. EDIT-B is an in vitro diagnostic test based on machine learning (ML) method integrating clinical metadata with adenosine-to-inosine (A-to-I) RNA editing signatures in eight genes ( GAB2 , IFNAR1 , IL17RA , LYN , MDM2 , PRKCB , PTPRC , ZNF267 ) to differentiate BD from MDD. Objective The objective of this study is to assess and confirm the diagnostic performance o…

By the Truvace desk2 min read1 sourcePeer-reviewedTRV-2026-1851· cite & verify
EDIT-B consortium: an external pan-European validation of an innovative machine learning-based test for bipolar disorder diagnosis
Granada - Hospital Doctor Olóriz 2 by Zarateman. CC0 · http://creativecommons.org/publicdomain/zero/1.0/deed.en

In brief

Researchers tested EDIT-B, an in vitro diagnostic that combines clinical metadata with RNA editing signatures in eight genes, in a new double-blind cohort. The 393 patients, all in a current major depressive episode, were recruited at four centres in Spain, France and Denmark, and test results were compared with physician diagnoses.

Telling bipolar disorder from major depression during a depressive episode is hard, and errors can lead to inappropriate treatment. The reported accuracy supports the test as an adjunct to clinical judgment, but the benefits listed for diagnostic delay, treatment tailoring and therapeutic alliance are described as potential rather than measured outcomes.

Main points

  1. The cohort included 393 patients: 238 with major depressive disorder and 155 with bipolar disorder.
  2. The area under the curve was 0.873, with sensitivity of 82.6% and specificity of 80.3%.
  3. Results were consistent across sites and across all stratified patient subgroups, matching earlier findings.
  4. Explainability analysis ranked the RNA editing biomarkers as the most important variables in the model's diagnoses.

The gain

In an independent double-blind multicentre cohort, the EDIT-B test distinguished bipolar disorder from major depressive disorder with about 83% sensitivity and 80% specificity, offering a complementary aid for a hard diagnostic problem.

The rundown

EDIT-B is a machine learning test that integrates clinical metadata with adenosine-to-inosine RNA editing signatures in eight named genes: GAB2, IFNAR1, IL17RA, LYN, MDM2, PRKCB, PTPRC and ZNF267. It is designed to separate bipolar disorder from major depressive disorder.

The validation used an independent, double-blind, external, multicentre European cohort, with the test compared against physician diagnoses. Explainability and sensitivity analyses were run to identify which variables drive the model, and the registration number is NCT05603819.

The authors conclude that RNA editing combined with machine learning is a reliable approach and call the test a complementary tool for psychiatric practice. They suggest it may reduce misdiagnosis and inappropriate treatment, framed as potential impact toward precision psychiatry.

Sources

  1. Peer-reviewedBMJ Mental Health2026-10-05

The debate